Table: Rohto -2015/16 group results

Rohto Pharmaceutical

13/05/2016 07:00

May 13 (Reuters)-  
          Rohto Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            167.02          151.77         163.00        75.00     
                 (+10.0 pct)     (+5.5 pct)     (-2.4 pct)    (-3.0 pct)  
  Operating         15.68           13.16          15.50         7.00     
                 (+19.2 pct)     (-21.8 pct)    (-1.2 pct)    (-2.4 pct)  
  Recurring         15.34           14.10          15.20         6.80     
                 (+8.8 pct)      (-17.6 pct)    (-0.9 pct)    (-9.5 pct)  
  Net 
  Net                9.10            8.63           9.50         4.30     
                 (+5.4 pct)      (-3.5 pct)     (+4.4 pct)   (-11.8 pct)  
  EPS             80.04 yen       76.05 yen      83.52 yen    37.80 yen   
  EPS Diluted     79.70 yen       75.73 yen                               
  Ann Div         20.00 yen       19.00 yen      21.00 yen                
  -Q2 Div         10.00 yen       9.00 yen       10.00 yen                
  -Q4 Div         10.00 yen       10.00 yen      11.00 yen                
   
  NOTE - Rohto Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T 
  ((Tokyo Headline News Desk +813 6441 1812))